摘要
目的:探讨可溶性MICA(sMICA)在胆管癌患者外周血中的表达及其临床意义。方法:应用酶联免疫吸附试验法(ELISA)检测42例胆管癌患者的外周血sMICA的表达水平,分析其与临床病理特征的关系。结果:胆管癌患者血清sMICA水平显著高于正常对照组(P<0.01);胆管癌患者血清中sMICA的表达水平与血清中CA19-9水平、肿瘤浸润及淋巴结转移等临床病理特征密切相关(P<0.05);手术后胆管癌患者血清中sMICA水平明显下降。结论:胆管癌患者血清中sMICA水平明显增高,血清sMICA可作为胆管癌诊断的一种重要的指标。
Objective: To investigate the expression of serum soluble MICA protein in peripheral blood in the patients with cholangiocarcinoma and its clinical significance.Methods: Samples of 42 cholangiocarcinoma patients and 40 healthy persons were col-lected to detect Serum levels of sMICA by MICA-specific enzyme-linked immunosorbent assay.The association of serum sMICA levels wth clinical features were statistically analyzed.Results: The serum levels of sMICA was found to be significantly elevated in the pa-tients with cholangiocarcinoma compared with heathy subjects(P0.01).The levels of sMICA correlated significantly with CA19-9 level,tumor infltration and lymph node metastasis(all P0.05).The successful tumor resection significantly decreased serum levels of soluble MICA.Conclusion: Serum MICA levels of patients with cholangiocarcinoma are significantly increased,it is one of the important param-eters for clinical evaluation in patients with cholangiocarcinoma.
出处
《现代生物医学进展》
CAS
2011年第14期2699-2701,共3页
Progress in Modern Biomedicine
关键词
胆管癌
可溶性MICA
临床病理
Cholangiocarcinoma
Soluble MICA
Clinical Pathology